Orforglipron is a once-daily oral GLP-1 tablet used in the management of obesity. In the U.S. orforglipron is sold under the brand name Foundayo, which was approved by the FDA in April 2026.
One of the main things that makes orforglipron different is that it is a tablet rather than an injection. Like other GLP-1 medicines, the dose is started low and increased gradually to help your body adjust and reduce the risk of stomach-related side effects.
It is important to note that dose schedules can vary slightly depending on the country, the product licence, and your prescriber’s advice. The guide below is based on the official orforglipron prescribing information.
The starting dose of orforglipron is 0.8mg once daily. This low starting dose is used to help your body get used to the medicine before moving up to stronger doses.
Starting low is important because GLP-1 medicines commonly cause stomach side effects early on, especially when treatment begins or the dose is increased.
Further reading: Orfoglipron side effects
There is not one single maintenance dose that suits everyone. Based on the official dosing schedule, the orforglipron maintenance dose can be any of the following doses: 5.5mg, 9mg, 14.5mg, or 17.2mg once daily, depending on how well the medicine is working and how well they tolerate it.
In practice, the right maintenance dose is usually the lowest effective dose that gives good appetite control, weight-loss benefit, and manageable side effects. That decision should be made with a prescriber.
The highest dose of orforglipron is 17.2mg once daily.
In clinical trials, orforglipron 17.2mg helped people lose around 12.4% of their starting body weight over 72 weeks.
Some medicines can affect how orforglipron is processed in the body. If you are taking medication that interacts with orforglipron, your prescriber may limit your dose to a maximum of 9mg once daily.
The dose of orforglipron is increased monthly. You will need to have taken it for at least 30 days, before increasing the dose.
Some people may need to stay on their current dose for longer to give their body more time to adjust before moving up. If you reach a dose that is helping to control your appetite and support weight loss, there may be no need to increase further. For many people, this is often seen from the 9 mg dose onwards.
A simple way to think about it is:
| Month | Daily dose |
|---|---|
| Month 1 | 0.8mg once daily |
| Month 2 | 2.5mg once daily |
| Month 3 | 5.5mg once daily |
| Month 4 | 9mg once daily if needed and tolerated |
| Month 5 | 14.5mg once daily if needed and tolerated |
| Month 6 | 17.2mg once daily if needed and tolerated |
Orforglipron is started on a low introductory dose to help your body get used to the medicine and reduce the risk of side effects. This first dose is not where the best weight loss results are usually seen. The stronger effects tend to come at the higher doses, which is why the dose is increased gradually over time. Some people do notice good appetite suppression on lower doses and may choose to stay there, but overall, higher doses are more likely to produce greater weight loss.
If you miss a dose of orforglipron, take it as soon as you remember. Do not take two doses together or double up your next dose.
If you have missed 7 or more days in a row, you may need to restart on a lower dose and increase gradually again to help reduce the risk of side effects. If this happens, speak to your prescriber or pharmacist for advice.
Orforglipron’s dosing schedule is designed to help your body build up tolerance gradually, especially before moving to the higher doses, which are generally linked with greater average weight loss.
That does not mean everyone will need the highest dose. Some people may find that a lower dose is already helping to reduce appetite and support weight loss, and in those cases, it may be appropriate to stay there rather than keep increasing.
In practice, this should be an individualised decision made with your doctor or pharmacist, based on how well the medicine is working for you and how well you are tolerating it.
It is also important to note that this article is based on orforglipron’s official U.S. prescribing information. UK prescribing advice is likely to be the same, but there is a chance it could differ if and when orforglipron is authorised in the UK.
Further reading: Where to buy orforglipron in the UK?
No. Orforglipron is designed to be taken once daily, not every other day. The prescribing information says to take it orally once a day and not to take more than one tablet per day.
Orforglipron can be taken with or without food.
There is no single best time of day to take orforglipron. The main thing is to take it once a day at a time you can stick to consistently.
Generally, higher doses tend to lead to greater average weight loss, which is why the dose is increased gradually over time. In the ATTAIN-1 trial, the highest dose produced the greatest average weight loss, although individual response can vary and some people do well on lower doses.
Increasing too quickly can make side effects more likely, especially stomach-related symptoms such as nausea, vomiting, diarrhoea, indigestion, abdominal pain and bloating.
The official dosing schedule is designed to reduce this risk by stepping up gradually.
Yes. Dose increases are based on treatment response and tolerability, so if side effects are bothering you, it may make sense to stay on your current dose for longer before moving up.
If you are struggling with side effects, you should speak to your prescriber or pharmacist before increasing further. They may advise you to stay on your current dose longer, or in some cases review whether the medicine is still suitable for you.
In practice, if a dose is not suiting you, your prescriber may decide that reducing to a lower dose is the safest option.
Whilst all of our content is written and reviewed by healthcare professionals, it is not intended to be substituted for or used as medical advice. If you have any questions or concerns about your health, please speak to your doctor.